Table of contents

Extended reports

• Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3 (12 May, 2004)

  M Guévremont, J Martel-Pelletier, C Boileau, F-T Liu, M Richard, J-C Fernandes, J-P Pelletier, P Reboul
• Doppler ultrasound findings in healthy wrists and finger joints (12 May, 2004)

  L Terslev, S Torp-Pedersen, E Qvistgaard, P von der Recke, H Bliddal
• Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis (12 May, 2004)

  J P Morko, M Söderström, A-M K Säämänen, H J Salminen, E I Vuorio
• Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in mice (12 May, 2004)

  K Joronen, R Ala-aho, M-L Majuri, H Alenius, V-M Kähäri, E Vuorio
• Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis (22 March, 2004)

  M Rudwaleit, J Listing, J Brandt, J Braun, J Sieper
• Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis (12 May, 2004)

  R Imrich, J Rovensky, M Zlnay, Z Radikova, L Macho, M Vigas, J Koska
• Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study (12 May, 2004)

  L Gossec, M Dougados, P Goupille, A Cantagrel, J Sibilia, O Meyer, J Sany, J-P Daurès, B Combe
• Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis (12 May, 2004)

  R Nissinen, M Leirisalo-Repo, R Peltomaa, T Palosuo, O Vaarala
• A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis (12 May, 2004)

  J R Kirwan, R Hällgren, H Mielants, F Wollheim, E Bjorck, T Persson, C Book, S Bowman, M Byron, N Cox, M Field, L Kanerud, M Leirisalo-Repo, M Malaise, A Mohammad, R Palmer, I F Petersson, B Ringertz, P Sheldon, M Simonsson, N Snowden, F Van den Bosch
• High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcγR triggering (12 May, 2004)

  T R D J Radstake, P L E M van Lent, G J Pesman, A B Blom, F G J Sweep, J Rönnelid, G J Adema, P Barrera, W B van den Berg
• Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2×2 factorial design (12 May, 2004)

  P Ravaud, B Giraudeau, I Logeart, J S Larguier, D Rolland, R Treves, L Euller-Ziegler, B Bannwarth, M Dougados
• Detecting structural changes in early experimental osteoarthritis of tibial cartilage by microscopic magnetic resonance imaging and polarised light microscopy (12 May, 2004)

  H A Alhadlaq, Y Xia, J B Moody, J R Matyas
• A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis

  (12 May, 2004)

  N Dalbeth, S Yeoman, J L Dockerty, J Highton, E Robinson, P L Tan, D Herman, F M McQueen
• Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC₃ study

  (12 May, 2004)

  H S J Picavet, N Hoeymans
• Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies (12 May, 2004)

  G Espinosa, S Bucciarelli, R Cervera, M Lozano, J-C Reverter, G de la Red, V Gil, M Ingelmo, J Font, R A Asherson